Literature DB >> 8242387

Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211.

V Nadler1, R Mechoulam, M Sokolovsky.   

Abstract

The effects of the synthetic non-psychoactive cannabinoid (+)-(3S,4S)-7-hydroxy-delta 6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) on the activity of the N-methyl-D-aspartate (NMDA) receptor/ion channel were examined. HU-211 non-competitively blocks the increase in binding of [3H]N-[1-(2-thienyl)-cyclohexyl]piperidine ([3H]TCP) induced by the polyamines spermine and spermidine or by glutamate and glycine. HU-211 does not, however, affect the direct binding of [3H]glycine and [3H]glutamate to their binding sites on the NMDA receptor, which suggests that the effects of HU-211 are not mediated via the binding sites of glutamate-, glycine- and phencyclidine-like drugs or of polyamines. HU-211 can also block 45Ca2+ uptake through the NMDA-receptor/ion channel in primary cell cultures of rat forebrain. All of the above inhibitory effects of HU-211 on the NMDA-receptor/ion channel activity are stereospecific, since the (-)(3R,4R) enantiomer (HU-210) is ineffective.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242387     DOI: 10.1016/0006-8993(93)90804-v

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage.

Authors:  Basma Shouman; Romain H Fontaine; Olivier Baud; Leslie Schwendimann; Matthias Keller; Michael Spedding; Vincent Lelièvre; Pierre Gressens
Journal:  Br J Pharmacol       Date:  2006-05-08       Impact factor: 8.739

Review 2.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  Derivatives of Dexanabinol. I. Water-soluble salts of glycinate esters.

Authors:  E Pop; Z Z Liu; M E Brewster; Y Barenholz; V Korablyov; R Mechoulam; V Nadler; A Biegon
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

4.  Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction.

Authors:  H Schuel; E Goldstein; R Mechoulam; A M Zimmerman; S Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

5.  The protective effect of dexanabinol (HU-211) on nitric oxide and cysteine protease-mediated neuronal death in focal cerebral ischemia.

Authors:  Ramazan Durmaz; Hilmi Ozden; Güngör Kanbak; Erinç Aral; Okan Can Arslan; Kazim Kartkaya; Kubilay Uzuner
Journal:  Neurochem Res       Date:  2008-04-11       Impact factor: 3.996

Review 6.  Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection.

Authors:  Sandeep Vasant More; Dong-Kug Choi
Journal:  Mol Neurodegener       Date:  2015-04-08       Impact factor: 14.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.